KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non –small-cell lung cancer

ConclusionThe combination of epacadostat plus pembrolizumab and chemotherapy was found to be tolerable in Japanese patients with advanced NSCLC.Trial registrationClinicalTrials.gov, NCT02862457.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research